Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Curcuminoids

PhytochemicalPolyphenolBest with a meal

Useful mainly for adults with osteoarthritis seeking pain relief; IBD patients on stable therapy needing adjunct.

Quick decision guide

May help most

Adults with osteoarthritis seeking pain relief; IBD patients on stable therapy needing adjunct

Common dosing range

500–2,000 mg/day of 95% curcuminoid extract; 200–500 mg/day of bioavailable formulations

When to expect effects

Weeks (pain); Months (IBD remission support)

Watch out for

Poor absorption unless using enhanced formulation; anticoagulant interaction; avoid in gallstone disease

What is it

Curcuminoids are a group of yellow polyphenols from turmeric (Curcuma longa) consisting primarily of curcumin (~75%), demethoxycurcumin (~15%), and bisdemethoxycurcumin (~5%). Standardized turmeric extracts target 95% total curcuminoids.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have osteoarthritis pain and want a non-NSAID adjunct with strong evidence

You have ulcerative colitis and are stable on medication, seeking a complementary approach

You choose a bioavailable formulation (phytosome, Theracurmin, BCM-95) to ensure absorption

Probably skip if…

You take anticoagulants or antiplatelets without medical supervision — potentiation risk

You have gallstones — curcumin stimulates gallbladder contraction and can precipitate pain

You are taking standard turmeric spice expecting the same dose as studied extract — dietary turmeric is far below therapeutic dose

Evidence at a glance

Goal	Effect	Best fit	Time
osteoarthritis pain Good Evidence	Comparable to low-dose NSAID for pain reduction in some head-to-head trials; moderate effect size	Adults with mild to moderate knee or hip osteoarthritis	Weeks
ulcerative colitis (adjunct to standard therapy) Good Evidence	Modest increase in remission rates when added to mesalazine	Adults with mild to moderate ulcerative colitis on stable conventional therapy	Months
depression (adjunct) Limited Evidence	Modest reduction in depression scores in small RCTs	Adults with mild to moderate depression as an adjunct to standard care	Weeks to months

osteoarthritis pain

Good Evidence

Effect: Comparable to low-dose NSAID for pain reduction in some head-to-head trials; moderate effect size
Best fit: Adults with mild to moderate knee or hip osteoarthritis
Time: Weeks

ulcerative colitis (adjunct to standard therapy)

Good Evidence

Effect: Modest increase in remission rates when added to mesalazine
Best fit: Adults with mild to moderate ulcerative colitis on stable conventional therapy
Time: Months

depression (adjunct)

Limited Evidence

Effect: Modest reduction in depression scores in small RCTs
Best fit: Adults with mild to moderate depression as an adjunct to standard care
Time: Weeks to months

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

osteoarthritis pain

Disease adjunct

Good Evidence

Multiple meta-analyses of RCTs consistently show that curcuminoid supplementation significantly reduces osteoarthritis pain scores (WOMAC, VAS) compared to placebo, with some head-to-head trials showing non-inferiority to ibuprofen with fewer GI adverse effects. Effect size is clinically meaningful in most pooled analyses.

Effect size

Comparable to low-dose NSAID for pain reduction in some head-to-head trials; moderate effect size

Time to effect

Weeks

Best fit

Adults with mild to moderate knee or hip osteoarthritis

Bottom line: The best-evidenced supplement use for osteoarthritis pain; bioavailable formulations preferred.

SourceZeng et al., 2021 — PMC Bideshki et al., 2024 — PubMed

ulcerative colitis (adjunct to standard therapy)

Disease adjunct

Good Evidence

RCTs including one well-designed trial (Hanai 2006) showed that 2 g/day curcumin added to mesalazine significantly increased clinical and endoscopic remission rates versus placebo plus mesalazine at 6 months. Meta-analyses are limited by small total sample sizes but trends are consistent. Curcumin is not a standalone UC treatment.

Effect size

Modest increase in remission rates when added to mesalazine

Time to effect

Months

Best fit

Adults with mild to moderate ulcerative colitis on stable conventional therapy

Less likely

Severe or refractory UC; curcumin not a substitute for standard treatment

Bottom line: Promising adjunct for UC in remission maintenance; not a replacement for standard therapy.

Evidence is mixed

Meta-analyses are positive but based on a small number of trials with limited sample sizes; larger confirmatory RCTs are needed.

SourceGoulart et al., 2020 — PubMed· conflicting Zheng et al., 2020 — PubMed· conflicting

SourceGoulart et al., 2020 — PubMed Zheng et al., 2020 — PubMed

depression (adjunct)

Disease adjunct

Limited Evidence

Several small RCTs and a meta-analysis report that curcumin at 500–1,500 mg/day reduces depression and anxiety symptom scores (HDRS, BDI) compared to placebo. Trials are typically short (4–8 weeks), small, and have heterogeneous populations. The mechanism may involve anti-inflammatory effects on neuroinflammation.

Effect size

Modest reduction in depression scores in small RCTs

Time to effect

Weeks to months

Best fit

Adults with mild to moderate depression as an adjunct to standard care

Less likely

Severe depression; curcumin should not replace established antidepressant therapy

Bottom line: Small positive signal for depression as an adjunct; evidence quality is too low to recommend as primary treatment.

Evidence is mixed

Positive meta-analyses exist but are driven by small trials with methodological limitations and high heterogeneity; larger definitive trials are absent.

SourceFusar-Poli et al., 2020 — PubMed· conflicting Ng et al., 2017 — PubMed· conflicting

SourceFusar-Poli et al., 2020 — PubMed Ng et al., 2017 — PubMed

How it works

Curcuminoids inhibit NF-kB, COX-2, 5-LOX, and several pro-inflammatory cytokines, providing anti-inflammatory activity comparable to NSAIDs in some clinical settings. They also modulate Nrf2 antioxidant signaling. Native curcumin has poor oral bioavailability (under 1%) due to rapid glucuronidation; modern formulations (phytosome/Meriva, BCM-95, Theracurmin, liposomal, nano-curcumin) achieve 5-30x higher plasma levels.

How to take it

1. Typical dose

500–2,000 mg/day 95% curcuminoid extract (with 20 mg piperine) OR 200–500 mg/day of enhanced formulation

2. Higher studied dose

3,000 mg/day used in some IBD trials

3. Timing

With meals

4. With food

With a fat-containing meal (curcumin is fat-soluble; enhanced formulations bypass this requirement)

5. Split dosing

Divide into 2–3 doses throughout the day

6. How long to try

4–8 weeks for pain assessment; 3–6 months for IBD or mood outcomes

What to track

Joint pain severity (use a simple 0–10 scale)

GI symptoms if using for IBD

Bleeding tendency if on blood thinners

Iron status at longer-term use (curcumin may reduce non-heme iron absorption)

3 commercial forms

Compare the main delivery options and what they’re best suited for.

95% curcuminoid extract + piperine

Common budget format.

Piperine slows glucuronidation; significantly improves blood levels.

Curcumin phytosome (Meriva)

Clinical trials with documented bioavailability.

Phospholipid complex; ~20x absorption.

Liposomal / nano curcumin

Premium-price formulations.

Higher absorption; varies by product.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Mild GI upset (nausea, diarrhea) at higher dosesStaining of teeth or tongue (yellow pigment)

Serious risks

Rare hepatotoxicity reported, possibly linked to specific products or piperine-enhanced formulations
May worsen iron-deficiency anemia by inhibiting non-heme iron absorption

Who should avoid it

People with gallstone disease or bile duct obstruction
People with iron-deficiency anemia taking non-heme iron sources
Those taking anticoagulants or antiplatelets without supervision

Pregnancy & breastfeeding

Avoid high-dose curcuminoid supplementation during pregnancy; culinary turmeric is safe.

Interactions

anticoagulants (warfarin) / antiplateletsMajor

Curcumin potentiates anticoagulant and antiplatelet effects; may increase bleeding risk

piperine (included in many products)Moderate

Piperine inhibits glucuronidation, raising plasma levels of many drugs including some antibiotics, anticonvulsants, and immunosuppressants

non-heme ironMinor

Curcumin chelates iron and reduces non-heme iron absorption; separate timing

Protocols featuring Curcuminoids

Evidence-backed routines where Curcuminoids plays a role.

Endometriosis Support

hormones

Endometriosis affects 10% of reproductive-age women and is one of the most under-diagnosed conditions in medicine — average diagnostic delay is 7-10 years. The pathology involves estrogen-dependent inflammatory lesions outside the uterus, driving severe menstrual pain, pelvic pain, painful intercourse, and infertility. Conventional treatment includes hormonal suppression (continuous oral contraceptives, GnRH analogs) and surgical excision. The supplement category has growing but still preliminary evidence: omega-3 EPA for inflammatory mediator modulation, magnesium for cramping and mood, NAC for lesion size reduction (small trial), and curcumin for inflammation. None of these replace proper medical management of confirmed endometriosis — they support symptom management alongside it. If you have severe menstrual pain that affects daily function, painful intercourse, infertility, or pelvic pain that doesn''t respond to over-the-counter pain relief — please see a gynecologist who specifically treats endometriosis. Many general OBs miss it.

Food sources

Food	Amount	%DV
Turmeric powder (1 tsp)	~70-90 mg curcuminoids	—
Fresh turmeric root	lower curcuminoid content than dried	—

Turmeric powder (1 tsp)

Amount: ~70-90 mg curcuminoids
%DV: —

Fresh turmeric root

Amount: lower curcuminoid content than dried
%DV: —

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

Bioavailability-enhanced formulation specified (phytosome/Meriva, BCM-95, Theracurmin, or liposomal)

Curcuminoid percentage clearly stated (95% standardized extract)

Piperine inclusion disclosed clearly on label

Be skeptical of…

'Cures cancer'

'Replaces anti-inflammatory medications'

'Equivalent to turmeric spice in your kitchen'

Frequently asked questions

Why is curcumin so poorly absorbed?⌄

It's rapidly conjugated by UGT enzymes. Bioavailable formulations or piperine help.

Is turmeric powder enough?⌄

For taste and modest effect, yes. For RCT-level doses, you need a concentrated extract.

References by claim

osteoarthritis pain

Zeng et al., 2021 — PMC (2021) link

Bideshki et al., 2024 — PubMed (2024) link

ulcerative colitis (adjunct to standard therapy)

Goulart et al., 2020 — PubMed (2020) link

Zheng et al., 2020 — PubMed (2020) link

depression (adjunct)

Fusar-Poli et al., 2020 — PubMed (2020) link

Ng et al., 2017 — PubMed (2017) link

Track Curcuminoids with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.